Unknown NA INTERVENTIONAL 5-arm NCT00099658

Safety of and Immune Response to a Pneumococcal Vaccine (PncCV) in HIV Infected and Uninfected Children

Evaluation of Quantitative and Qualitative Antibody Responses to Streptococcus Pneumoniae and Haemophilus Influenzae Type b Conjugate Vaccines Amongst HIV-1-Exposed-Infected Children That Are Receiving Vs. Those Not Receiving Antiretroviral Therapy, as Well as Among HIV-1-Exposed-Uninfected Children and HIV-1-Unexposed-Uninfected Children

Sponsor: CIPRA SA

Conditions HIV Infections Pneumococcal Infections

Interventions Pneumococcal polysaccharide-protein conjugate vaccine

Updated 6 times since 2017 Last updated: Feb 14, 2011 Started: Apr 30, 2005 Primary completion: Dec 31, 2013 Completion: Jun 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on HIV Infections and Pneumococcal Infections, this trial is ongoing. The trial is conducted by CIPRA SA and has accumulated 6 data snapshots since 2005. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Feb 2017 — Jun 2018 [monthly]

Unknown Status NA

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Unknown Status NA

First recorded

Apr 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CIPRA SA
National Institute of Allergy and Infectious Diseases (NIAID)

Data source: CIPRA SA

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.